Pacer Advisors Inc. boosted its holdings in HealthSouth Corp (NYSE:HLS) by 29.6% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 15,377 shares of the company’s stock after buying an additional 3,509 shares during the period. Pacer Advisors Inc.’s holdings in HealthSouth were worth $713,000 as of its most recent SEC filing.
Other hedge funds have also modified their holdings of the company. First Mercantile Trust Co. increased its stake in HealthSouth by 18.8% in the 2nd quarter. First Mercantile Trust Co. now owns 2,720 shares of the company’s stock worth $132,000 after buying an additional 430 shares in the last quarter. Acrospire Investment Management LLC grew its position in shares of HealthSouth by 64.7% during the second quarter. Acrospire Investment Management LLC now owns 2,800 shares of the company’s stock valued at $136,000 after purchasing an additional 1,100 shares in the last quarter. Advisor Group Inc. grew its position in shares of HealthSouth by 33.8% during the second quarter. Advisor Group Inc. now owns 3,092 shares of the company’s stock valued at $149,000 after purchasing an additional 781 shares in the last quarter. Petrus Trust Company LTA purchased a new position in shares of HealthSouth during the second quarter valued at about $210,000. Finally, HL Financial Services LLC purchased a new position in shares of HealthSouth during the second quarter valued at about $213,000. Institutional investors and hedge funds own 93.39% of the company’s stock.
A number of brokerages have recently weighed in on HLS. William Blair restated an “outperform” rating on shares of HealthSouth in a research report on Tuesday, November 21st. Royal Bank Of Canada restated a “buy” rating on shares of HealthSouth in a research report on Wednesday, November 15th. Mizuho upgraded HealthSouth from a “neutral” rating to a “buy” rating and set a $55.00 price objective for the company in a research report on Thursday, November 2nd. Zacks Investment Research lowered HealthSouth from a “buy” rating to a “hold” rating in a research report on Tuesday, October 31st. Finally, Robert W. Baird restated a “buy” rating and set a $55.00 price objective on shares of HealthSouth in a research report on Monday, October 9th. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating and six have assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of $51.75.
Shares of HealthSouth Corp (NYSE:HLS) traded down $0.98 during trading on Tuesday, hitting $48.18. The stock had a trading volume of 698,500 shares, compared to its average volume of 905,582. The stock has a market capitalization of $4,832.96, a price-to-earnings ratio of 17.62, a price-to-earnings-growth ratio of 1.81 and a beta of 0.52. The company has a current ratio of 1.34, a quick ratio of 1.34 and a debt-to-equity ratio of 1.89. HealthSouth Corp has a 52-week low of $38.24 and a 52-week high of $50.06.
HealthSouth (NYSE:HLS) last released its quarterly earnings results on Thursday, October 26th. The company reported $0.66 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.65 by $0.01. The company had revenue of $995.60 million during the quarter, compared to analyst estimates of $985.75 million. HealthSouth had a return on equity of 22.81% and a net margin of 6.69%. The firm’s revenue was up 7.4% on a year-over-year basis. During the same quarter last year, the business posted $0.65 earnings per share. sell-side analysts forecast that HealthSouth Corp will post 2.72 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, January 16th. Investors of record on Tuesday, January 2nd will be given a $0.25 dividend. The ex-dividend date is Friday, December 29th. This represents a $1.00 annualized dividend and a yield of 2.08%. HealthSouth’s dividend payout ratio is currently 36.36%.
HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.
Want to see what other hedge funds are holding HLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthSouth Corp (NYSE:HLS).
What are top analysts saying about HealthSouth Corp? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for HealthSouth Corp and related companies.